<i>De novo</i> monosomy 9p24.3‐pter and trisomy 17q24.3‐qter characterised by microarray comparative genomic hybridisation in a fetus with an increased nuchal translucency

Abstract

This case illustrates that microarray CGH is a rapid, powerful and sensitive technology to identify small de novo unbalanced chromosomal abnormalities and can be applied in prenatal diagnosis.